NanoFlex Power (OPVS) 10-K 10 Apr 15 2014 FY Annual report Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
	Dec. 31, 2014	Apr. 10, 2015	Jun. 30, 2014
Document And Entity Information [Abstract]
Entity Registrant Name	NanoFlex Power Corp
Entity Central Index Key	1571636
Amendment Flag	FALSE
Current Fiscal Year End Date	-19
Document Type	10-K
Document Period End Date	31-Dec-14
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2014
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Smaller Reporting Company
Entity Public Float			$14,174,059
Entity Common Stock, Shares Outstanding		44,295,928

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Dec. 31, 2014	Dec. 31, 2013
CURRENT ASSETS:
Cash	$168	$197,004
Prepaid expenses and other current assets	5,519	13,645
Total current assets	5,687	210,649
Property and equipment, net	13,678	7,433
TOTAL ASSETS	19,365	218,082
CURRENT LIABILITIES:
Accounts payable	1,857,911	689,119
Accounts payable- related party	48,064
Accrued expenses	1,958,403	676,752
Short-term debt	100,000	100,000
Short-term debt- related party	150,000
Convertible debt, net of discount	673,389
Advances - related party	428,150
Total current liabilities	5,215,917	1,465,871
TOTAL LIABILITIES	5,215,917	1,465,871
STOCKHOLDERS' DEFICIT:
Common stock, 250,000,000 authorized, $0.0001 par value, 44,306,278 and 42,799,278 issued and outstanding, respectively	4,431	4,280
Additional paid in capital	173,025,473	171,010,959
Accumulated deficit	-178,226,456	-172,263,028
Total stockholders' deficit	-5,196,552	-1,247,789
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$19,365	$218,082

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parenthetical) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Balance Sheets [Abstract]
Common Stock, shares authorized	250,000,000	250,000,000
Common Stock, par value per share	$0.00	$0.00
Common Stock, shares issued	44,306,278	42,799,278
Common stock, shares outstanding	44,306,278	42,799,278

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
OPERATING EXPENSES:
Research and development	$1,174,473	$1,390,438
Patent application and prosecution fees	2,394,118	2,069,530
Salaries and related expenses	1,201,959	1,900,690
Selling, general and administrative expenses	1,112,356	27,475,129
Total operating expenses	5,882,906	32,835,787
LOSS FROM OPERATIONS	5,882,906	32,835,787
OTHER INCOME (EXPENSES):
Interest expense	-80,522	-4,591,153
Loss on extinguishment of debt		-1,811,800
Total other expense	-80,522	-6,402,953
LOSS BEFORE INCOME TAX BENEFIT	5,963,428	39,238,740
INCOME TAX BENEFIT
NET LOSS	($5,963,428)	($39,238,740)
NET LOSS per share (basic and diluted)	($0.14)	($0.59)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING, BASIC and DILUTED	43,640,824	66,855,209

Consolidated_Statement_of_Chan

Consolidated Statement of Changes in Stockholders' Deficit (USD $)	Total	Common Stock	Additional Paid in Capital	Accumulated Deficit
Beginning balance at Dec. 31, 2012	($7,268,162)	$1,609	$125,754,517	($133,024,288)
Beginning balance (in shares) at Dec. 31, 2012		16,091,909
Common shares issued for warrant exercise	176,819	6	176,813
Common shares issued for warrant exercise (in shares)		60,070
Common shares issued for services	25,971,940	286	25,971,654
Common shares issued for services (in shares)		2,858,811
Common shares issued for loan extensions	1,758,900	29	1,758,871
Common shares issued for loan extensions (in shares)		286,000
Common shares issued to debt holders for additional interest	1,067,345	17	1,067,328
Common shares issued to debt holders for additional interest (in shares)		173,552
Common shares issued for default penalty interest	2,214,000	36	2,213,964
Common shares issued for default penalty interest (in shares)		360,000
Common shares issued to warrant holders for additional interest	733,695	12	733,683
Common shares issued to warrant holders for additional interest (in shares)		119,300
Common shares issued for consulting services	92,250		92,250
Common shares issued for consulting services (in shares)		15,000
Common shares issued for debt conversions	282,900	5	282,895
Common shares issued for debt conversions (in shares)		46,000
Common stock issued for cash	1,050,000	116	1,049,884
Common shares issued for cash (in shares)		1,155,000
Common shares issued for forgiveness of debt	162,915	12	162,903
Common shares issued for forgiveness of debt (in shares)		115,500
Reverse merger adjustment	5,149	966	4,183
Reverse merger adjustment (in shares)		9,658,936
Common shares issued for automatic conversion of debt due to merger	11,433,200	1,143	11,432,057
Common shares issued for automatic conversion of debt due to merger (in shares)		11,433,200
Return of equity investment	-222,500		-222,500
Return of equity investment (in shares)
Sale of common shares and warrants in PPM	532,500	43	532,457
Sale of common shares and warrants in PPM (in shares)		426,000
Net loss	-39,238,740			-39,238,740
Ending balance at Dec. 31, 2013	-1,247,789	4,280	171,010,959	-172,263,028
Ending balance (in shares) at Dec. 31, 2013		42,799,278
Common stock and warrants issued for cash	1,883,750	151	1,883,599
Common stock and warrants issued for cash, Shares		1,507,000
Recognition of contingent beneficial conversion feature and warrants	130,915		130,915
Net loss	-5,963,428			-5,963,428
Ending balance at Dec. 31, 2014	($5,196,552)	$4,431	$173,025,473	($178,226,456)
Ending balance (in shares) at Dec. 31, 2014		44,306,278

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	($5,963,428)	($39,238,740)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	3,819	3,393
Amortization of debt discounts	4,304	45,421
Stock-based compensation		26,064,190
Interest expense from convertible debt converted to preferred shares		57,915
Interest expense from additional common shares issued		4,015,040
Loss on extinguishment of debt		1,811,800
Return of equity investment		-222,500
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	8,126	12,784
Accounts payable and accrued expenses	2,498,507	-1,330,941
Net cash used in operating activities	-3,448,672	-8,781,638
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of fixed assets	-10,064	-6,182
Common shares issued in reverse merger, net		5,149
Net cash used in investing activities	-10,064	-1,033
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from exercise of warrants		176,819
Proceeds from sale of common shares and warrants	1,883,750	532,500
Proceeds from sale of common shares- related party		1,050,000
Advances received from related party	721,150
Advances repaid to related party	-293,000
Borrowings on related party debt	150,000	240,000
Borrowings on convertible debt- related party		6,800,000
Borrowings on convertible debt	800,000
Borrowing on convertible debt		2,124,500
Principal repayments on debt		-1,725,000
Principal repayments on related party debt		-563,800
Net cash provided by financing activities	3,261,900	8,635,019
NET DECREASE IN CASH	-196,836	-147,652
Cash, beginning of the period	197,004	344,656
Cash, end of the period	168	197,004
SUPPLEMENTAL CASH FLOW INFORMATION
Cash paid for interest		753,558
Cash paid for income taxes
NON-CASH INVESTING AND FINANCING ACTIVITIES
Warrants and common shares issued for debt		230,000
Common share issued for forgiveness of related party debt		105,000
Short term debt converted into convertible short term debt
Common shares issued for conversion of convertible debt upon merger		11,433,200
Discount on beneficial conversion feature and warrants	$130,915

Background_Basis_of_Presentati

Background, Basis of Presentation	12 Months Ended
	Dec. 31, 2014
Background, Basis of Presentation [Abstract]
Background, Basis of Presentation	Note 1: Background, Basis of Presentation:
	Background
	Global Photonic Energy Corporation (“GPEC”) was incorporated in Pennsylvania on February 7, 1994. The Company is a development stage company organized to fund, develop and commercialize photonic energy conversion technologies utilizing organic semiconductor-based solar cells. The Company intends to enter into licensing arrangements and other strategic alliances for the development, manufacture and marketing of products utilizing this technology.
	The technology is targeted at certain broad applications including 1) mobile electronic device power, 2) electric vehicle (EV) charging or “power paint”, 3) semi-transparent solar power generating windows or glazing and 4) traditional off-grid and grid-connected solar power generation. Laboratory feasibility prototypes have been developed that successfully demonstrate key building block principles for these technology application areas.
	Universal Technology Systems Corp. (“UTCH”) was incorporated in Florida on January 28, 2013.
	Global Photonic Energy Corporation merged with NanoFlex Power Corporation (formerly, Universal Technology Systems Corp., “we”, “our” or the “Company”) in a share exchange transaction recorded as a reverse merger on September 24, 2013.  The Company is organized to fund, develop and commercialize photonic energy conversion technologies utilizing organic semiconductor-based solar cells.  The Company intends to enter into licensing arrangements and other strategic alliances for the development, manufacture and marketing of products utilizing this technology. The Company is devoting substantially all of its present efforts to establishing a new business.
	Basis or Presentation
	The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. On an ongoing basis, we evaluate our estimates, including those related to revenue recognition, income taxes, inventory, long lived assets and contingencies. These estimates are based on management’s best knowledge of current events, historical experience, actions that we may undertake in the future and on various other assumptions that are believed to be reasonable under the circumstances. As a result, actual results could differ materially from these estimates and assumptions.
	Effective September 22, 2013, UTCH affected a 1.2-for-1 forward split of the outstanding common stock of the Company, par value $.0001.  All references to UTCH common stock have been retroactively restated to reflect the effect of the forward split.
	Merger
	On September 24, 2013, UTCH entered into a stock exchange agreement with GPEC and the shareholders of UTCH. Pursuant to the Share Exchange Agreement, UTCH issued 15,500,640 shares of its common stock, representing no less than 80% of the total issued and outstanding common stock of UTCH, to the shareholders of GPEC in exchange for 100% of the issued and outstanding capital stock of GPEC (the “Merger”). As a result of this transaction, GPEC became UTCH wholly-owned subsidiary, and UTCH acquired the business and operations of GPEC.
	For accounting purposes, this transaction was accounted for as a reverse merger and has been treated as a recapitalization of UTCH, where GPEC is considered the accounting acquirer, and the financial statements of the accounting acquirer became the financial statements of the registrant. The Company did not recognize goodwill or any intangible assets in connection with the transaction. Additionally all assets and liabilities of the Company were transferred to GPEC .The historical consolidated financial statements include the operations of the accounting acquirer for all periods presented.
	At the Closing, there were GPEC common shares of 77,503,198 , warrants of 9,586,416,  options of 525,000 and 5,255 series A Preferred convertible stock issued and outstanding.  As part of the Merger, GPEC shareholders of the Company as of September 24, 2013 received 1 common share of UTCH, Inc. for each 5 common shares, warrants, options and 1,100 common shares for each series A Preferred convertible stock owned of GPEC.
	Pursuant to the terms and conditions of the issued and outstanding 5,255 Series A Preferred of GPEC and the GPEC Bridge Notes of $11,433,200, UTCH issued to the holders of Series A Preferred: (i) a total of 5,780,500 shares of UTCH Common Stock and (ii) warrants to purchase a total of 5,780,500 shares of UTCH Common Stock and also issued to holders of the GPEC Bridge Notes: (i) a total of 11,433,200 shares of UTCH Common Stock and (ii) warrants to purchase a total of 11,433,200 shares of UTCH Common Stock, as a result of the automatic conversion of such  Series A Preferred and GPEC Bridge Notes.
	In addition, as of the Closing Date, there were issued and outstanding: (i) warrants to purchase an aggregate of 1,917,283 shares of GPEC Common Stock (“GPEC Warrants”) and (ii) options to purchase an aggregate of 105,000 shares of GPEC Common Stock (“GPEC Options).
	Sponsored Research Agreement
	Research and development of the Technology is being conducted at the University of Southern California (“USC”) and, on a subcontractor basis, at the University of Michigan, beginning 2006 and currently under a 5-year Sponsored Research Agreement dated May 1, 2009.  During this period, the Company has agreed to pay USC up to $6,338,341 for work to be performed.  On December 20, 2013, the Company entered into a Research Agreement with USC (“2013 Research Agreement”) to amend and replace the 2009 Research Agreement to continue the sponsored research at USC and Michigan from February 1, 2014 through January 31, 2021. On the same day, they have also entered into a Third Amendment to the License Agreement which renews and extends the License Agreement by and between USC, Michigan, Princeton and GPEC (“Third Amendment to License Agreement”). GPEC assigned to the Company and the Company assumed all the rights and obligations under both the 2013 Research Agreement and the Third Amendment to License Agreement.
	License Agreement
	The Company possesses an exclusive worldwide license and the right to sublicense any and all inventions and intellectual property resulting from the Company’s research agreements.  Royalties due under the agreement are 3% of revenues from sublicensing technology and 23% of revenues from any patent rights lawsuit proceeds.  Minimum royalties are as follows:
	Years ending December 31,
	2015	40,000
	2016	50,000
	2017	65,000
	2018	75,000
	2019	100,000
	2020 and thereafter	100,000

Going_Concern

Going Concern	12 Months Ended
	Dec. 31, 2014
Going Concern [Abstract]
Going Concern	Note 2: Going Concern
	The Company has not generated revenues to date.  The Company has a working capital deficit of $5,210,230 and an accumulated deficit of $178,226,456 as of December 31, 2014.  The ability of the Company to continue as a going concern is dependent on raising capital to fund ongoing operations and carry out its business plan and ultimately to attain profitable operations.  Accordingly, these factors raise substantial doubt as to the Company’s ability to continue as a going concern. The financial statements do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts of and classification of liabilities that might be necessary in the event the Company cannot continue in existence.

Summary_of_Significant_Account

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2014
Summary of Significant Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 3: Summary of Significant Accounting Policies
	Cash and Cash Equivalents
	For purposes of the statement of cash flows, the Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents.
	Principles of Consolidation
	The consolidated financial statements include the accounts of the Company and its controlled subsidiaries. Equity investments in which we exercise significant influence, but do not control and are not the primary beneficiary, are accounted for using the equity method of accounting. Investments in which we do not exercise significant influence over the investee are accounted for using the cost method of accounting. Intercompany transactions are eliminated.
	Property and Equipment
	Property and equipment are stated at cost.  Depreciation of property and equipment is provided using the straight-line method for financial reporting purposes at rates based on the estimated useful lives of the assets.  Estimated useful lives range from three to eight years.
	Impairment of Long-lived Assets
	The Company reviews the carrying value of its long-lived assets annually or whenever events or changes in circumstances indicate that the historical-cost carrying value of an asset may no longer be appropriate. The Company assesses recoverability of the asset by comparing the undiscounted future net cash flows expected to result from the asset to its carrying value. If the carrying value exceeds the undiscounted future net cash flows of the asset, an impairment loss is measured and recognized. An impairment loss is measured as the difference between the net book value and the fair value of the long-lived asset. Fair value is estimated based upon either discounted cash flow analysis or estimated salvage value.
	Stock-Based Compensation
	We account for stock based compensation in accordance with FASB ASC 718 which requires companies to measure the cost of employee services received in exchange for an award of an equity instrument based on the grant-date fair value of the award. For stock-based awards granted on or after January 1, 2006, stock-based compensation expense is recognized on a straight-line basis over the requisite service period. In prior years, we accounted for stock-based awards under APB No. 25, “Accounting for Stock Issued to Employees.” We account for non-employee share-based awards in accordance with FASB ASC 505-50.
	Use of Estimates
	The preparation of these financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that may affect certain reported amounts and disclosures in the financial statements and accompanying notes. The significant estimates relate useful lives of software licenses, valuation of beneficial conversion feature on convertible debts, valuation of warrants and stock options, and valuation allowance for deferred income taxes. Actual results could differ from those estimates.
	Credit Risk
	Cash is maintained in bank accounts which, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts and does not believe it is exposed to any significant credit risk on cash.
	Research and Development
	Research and development costs are expensed in the period they are incurred in accordance with ASC 730, Research and Development unless they meet specific criteria related to technical, market and financial feasibility, as determined by management, including but not limited to the establishment of a clearly defined future market for the product, and the availability of adequate resources to complete the project. If all criteria are met, the costs are deferred and amortized over the expected useful life, or written off if a product is abandoned. At December 31, 2014 and 2013, the Company had no deferred development costs.
	Fair Value of Financial Instruments
	The carrying value of short-term financial instruments, including cash, accounts receivable, accounts payable and accrued expenses, and short-term borrowings approximate fair value due to the relatively short period to maturity for these instruments. The long-term borrowings approximate fair value since the related rates of interest approximates current market rates.
	Income Taxes
	Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. These assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which the temporary differences are expected to reverse.
	We have net operating loss carry-forwards available to reduce future taxable income. Future tax benefits for these net operating loss carry-forwards are recognized to the extent that realization of these benefits is considered more likely than not. To the extent that we will not realize a future tax benefit, a valuation allowance is established.

New_Accounting_Pronouncements

New Accounting Pronouncements	12 Months Ended
	Dec. 31, 2014
Accounting Changes and Error Corrections [Abstract]
New Accounting Pronouncements	Note 4: New Accounting Pronouncements
	In the quarter ending June 30, 2014, the Company elected to early adopt Accounting Standards Update No. 2014-10, Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements. The adoption of this ASU allows the Company to remove the inception to date information and all references to development stage.

Debt

Debt	12 Months Ended
	Dec. 31, 2014
Debt Disclosure [Abstract]
Debt	Note 5: Debt
	Notes Payable
	During 2013, the Company repaid an aggregate of $1,725,000 to the third party creditors. In addition, an aggregate of $230,000 of debt was converted into 46,000 common shares.  As the debt was not originally convertible, the issuance of the shares to settle the debt was determined to be debt extinguishment. The fair value of the common shares was determined to be $282,900 and therefore a loss on debt extinguishment was recognized of $52,900.
	During 2013, the maturity date on an aggregate of $1,400,000 of outstanding debt was extended an additional 3 or 4 months. In connection with the extensions, the Company issued 286,000 common shares. The Company evaluated the modifications under ASC 470-50 determined that the modifications were substantial and the revised terms constituted debt extinguishments. The fair value of the common shares was determined to be $1,758,900, and accounted for as a loss on the extinguishment of debt. These notes were converted into the convertible notes see Note 6 and then converted into equity.
	During 2013, the aggregate amortization of other debt discounts totaled $45,421. These discounts were originally recorded during 2012, 2011 and 2010. At December 31, 2013, there is no unamortized debt discount remaining related to the discounts originally recorded during 2012, 2011 and 2010.
	The Company has a note payable due to Mr. Seligsohn, their former Chief Executive Officer and President. The note is due on demand and bears an interest rate at the minimum applicable rate for loans of similar duration, which was 0.5% as of December 31, 2014.
	Notes Payable – Related Party
	On February 26, 2014, the Company borrowed $150,000 under a short term note agreement with a related party. Under the terms of this agreement, this note is due to be repaid within 6 months of funding and is non-interest bearing.  If the Company defaults on this agreement, the note shall bear interest at a rate of 18 percent per annum for the entire term of the note. In November 2014, the note agreement was amended to extend the due date to February 26, 2015, 12 months from the date of the note. As of December 31, 2014, $22,784 was recorded as accrued interest relating to this note.
	Advances – Related Party
	During the year ended December 31, 2014, the Company received advances from its Chief Executive Officer totaling $721,150 and repaid advances totaling $293,000. Such advances do not accrue interest and are payable upon demand.
	Convertible Notes Payable
	During 2013, the Company modified $2,432,500 of its outstanding short term debt whereby the notes become convertible. Additionally, from July 1, 2013 through September 24, 2013, the Company borrowed $2,124,500 from private investors.  The notes were unsecured, bear interest at 5% per annum and had a maturity date of December 31, 2013. The notes converted upon the completion of the reverse merger and converted into units of UTCH. Each unit consists of (i) one share of the Common Stock and (ii) one warrant to purchase one share of the Common Stock. The conversion price is $1 per unit. The warrant may be exercised at a purchase price of $2.50 per share. The holder has a period to exercise of 5 years from the date of issuance. The Company analyzed the conversion options in the Convertible Promissory notes for derivative accounting consideration under ASC 815, Derivative and Hedging, and determines that the transactions do not qualify for derivative treatment. Further, the Company determined that there is no discount to be recognized under accounting for beneficial conversion feature as these notes were automatically converted into the Public Company stock upon completion of a merger which closed on September 24, 2013. On September 24, 2013, the Company issued 4,557,000 common shares and 4,557,000 warrants for the conversion of these notes.
	In July 2014, the Company borrowed $500,000 under two short term note agreements of $250,000 each. Under the terms of each agreement, the principal balance of $250,000 and interest of $16,500 is due to be repaid within 4 months of the date of the note. These agreements were amended to extend the due date to July 21, 2015 and increase the interest amount to $25,000. The Company analyzed the amendment of the note under ASC 470 and concluded that the amendment did not qualify as a substantial modification. At December 31, 2014, $50,000 was recorded as accrued interest relating to these notes. The agreements allow the holder to convert all or a portion of the principal and accrued interest into equity as a conversion rate of $1.25. There is no BCF since the conversion is $1.25 which equal to the $1.25 units being sold.
	On December 19, 2014, the Company received aggregate proceeds of $300,000 in exchange for a convertible note and the issuance of 200,000 warrants with a five year life and an exercise price of $2.5 per share.  The convertible note has a principal amount of $300,000, interest of 8% per annum, a maturity date of December 19, 2015, and is convertible into 300,000 units, with each unit consisting of a share of common stock and a warrant with a five year life from the date of conversion and an exercise price of $1 per share, subject to certain anti-dilution provisions.  The Company allocated the proceeds to the warrants and the convertible debt based on their respective fair values, then computed the effective conversion price of each instrument, noting that the convertible debt gave rise to a beneficial conversion feature in accordance with the provisions of ASC 470-20 “Debt – Debt with Conversion and Other Options”.  Of the $300,000 proceeds received, $71,369 was allocated to the warrants, and $59,546 was allocated to the beneficial conversion feature, each of which are reflected in additional paid-in-capital.  This allocation gave rise to a debt discount of $130,915 which is being amortized on a straight-line basis over the term of the note.  The Company recognized interest expense of $4,304 associated with the amortization of debt discount for the year ended December 31, 2014.
	Convertible Notes Payable – Related Party
	During 2013, the Company borrowed $6,800,000 from a majority shareholder. These loans were convertible short term note agreements. The notes were unsecured, bore interest at 5% per annum and had a maturity date of December 31, 2013. The notes converted upon the completion of the reverse merger and converted into units of UTCH. Each unit consisted of (i) one share of the Common Stock and (ii) one warrant to purchase one share of the Common Stock. The conversion price was $1 per unit. The warrant may be exercised at a purchase price of $2.50 per share. The holder has a period to exercise of 5 years from the date of issuance. The Company analyzed the conversion options in the Convertible Promissory notes for derivative accounting consideration under ASC 815, Derivative and Hedging, and determines that the transactions do not qualify for derivative treatment. Further, the Company determined that there is no discount to be recognized under accounting for beneficial conversion feature as these notes were automatically converted into the Public Company stock upon completion of a merger which closed on September 24, 2013. On September 24, 2013, the Company issued 6,800,000 common shares and 6,800,000 warrants for the conversion of these notes.
	The Company converted outstanding accrued interest of $105,000 due to a majority shareholder, into 115,500 common shares. The relative fair value of these shares was determined to be $57,915 and it was recorded as a debt discount. The full discount was amortized to interest expense during 2013.
	In addition, the Company borrowed $240,000 in the form of short term related party notes and repaid $563,800 and converted $76,200 into common shares upon complete of the reverse merger (see note 1) during 2013. As of December 31, 2013, the balance due is $100,000.
	On September 24, 2013, the Company issued 76,200 common shares and 76,200 warrants for the conversion of these notes.
	Accounts Payable – Related Party
	The Company has recorded $48,064 in accounts payable for expenses paid by Joey Stone, Senior Vice President of Corporate Development and John D. Kuhns, former co-Chief Executive Officer and former Executive Chairman of the Board on behalf of the company.

Equity

Equity	12 Months Ended
	Dec. 31, 2014
Equity [Abstract]
Equity	Note 6. Equity
	During 2013, the Company issued the following shares of common stock:
		·	60,070 common shares issued for the exercise of warrants with cash proceeds of $176,819.
		·	2,858,811 common shares issued to officers as compensation, with the fair value of the shares of $25,971,940 recognized as stock-based compensation. The shares are fully vested.
		·	286,000 common shares issued for loan extensions valued at $1,758,900
		·	173,552 common shares issued to note holders as additional interest, with the fair value of the shares of $1,067,345 recognized as interest expense.
		·	360,000 common shares issued to a third party note holder in accordance to the default terms of the 2010 and 2011 notes. The fair value of the shares was determined to be $2,214,000 and was recognized as interest expense.
		·	119,300 common shares issued in aggregate to certain warrant holders as additional interest, with fair value of the shares of $733,695 recognized as interest expense.
		·	15,000 common shares issued for consulting services, with fair value of the shares of $92,250 recognized as stock based compensation. The shares vested immediately.
		·	46,000 common shares issued for the conversion of short term debt valued at $282,900.
		·	1,155,000 common shares issued for cash to a majority shareholder for proceeds of 1,050,000.
		·	115,500 common shares issued to a majority shareholder valued at $162,915, to convert $105,000 of interest due to him.
		·	9,658,936 shares of common stock, representing shares held by UTCH immediately prior to the Merger, are reflected as an increase in shares outstanding during 2013 as a result of the Merger.
		·	During 2013, the Company sold an aggregate of 426,000 units at $1.25 unit for $532,500. Each unit consisted of one common share and one warrant. Each warrant is exercisable for a period of five years from the date of issuance, at $2.50 per share.
	During 2013, the Company paid common shareholders $130,000 for the return of equity investment of $225,000. The Company recorded the cash paid and return of equity as additional interest expense. The common shares will be cancelled when returned. The common shares have not been returned as of December 31, 2014.
	During 2014, the Company sold an aggregate of 1,507,000 units at $1.25 per unit for aggregate proceeds of $1,883,750. Each unit consisted of one common share and one warrant. Each warrant is exercisable for a period of five years from the date of issuance, at $2.50 per share.

Stock_Options_and_Warrants

Stock Options and Warrants	12 Months Ended
	Dec. 31, 2014
Stock Options and Warrants [Abstract]
Stock Options and Warrants	Note 7. Stock Options and Warrants
	2000 Stock Option Plan
	On April 28, 2000, the Board of Directors adopted the 2000 Stock Option Plan.  Under the Plan, the Company may grant incentive stock options to employees and non-qualified stock options to employees, non-employee directors and/or consultants.   The Plan provides for the granting of a maximum of 2,000,000 options to purchase common stock.  The ISO exercise price per share may not be less than the fair market value of a share on the date the option is granted.  The maximum term of the options may not exceed ten years.
	A summary of stock option activity during the year ended December 31, 2014 and 2013 is as follows:
							Weighted
							Average
					Weighted		Remaining
		Number of			Average		Contractual		Aggregate
					Exercise		Term		Intrinsic
		Shares			Price		(in years)		Value
	Outstanding as of December 31, 2012		137,000		$	9.7		1.9	$	-
	Granted		-
	Cancelled		(32,000	)	$	10.06
	Exercised		-
	Outstanding as of December 31, 2013		105,000		$	11.03		2.6	$	-
	Granted		-
	Cancelled		(56,000	)	$	10.26
	Exercised		-
	Outstanding as of December 31, 2014		49,000		$	11.01		1.8	$	-
	Exercisable as of December 31, 2014		49,000		$	11.92		1.8	$	-
	The exercise price of these options range from $10.00 to $15.00 per share.
	Warrants
	A summary of warrant activity during the year ended December 31, 2014 and 2013 is as follows:
							Weighted
							Average
					Weighted		Remaining
		Number of			Average		Contractual		Aggregate
					Exercise		Term		Intrinsic
		Shares			Price		(in years)		Value
	Outstanding as of December 31, 2012		2,007,083		$	13.9		14	$	-
	Granted		17,639,700		$	0.4
	Cancelled		(24,750	)	$	5.56
	Exercised		(65,050	)	$	13.36
	Outstanding as of December 31, 2013		19,556,983		$	3.6		4.7	$	-
	Granted		1,707,000		$	2.5
	Cancelled		(12,000	)
	Exercised		-
	Outstanding as of December 31, 2014		21,251,983		$	3.02		3.8	$	-
	Exercisable as of December 31, 2014		21,251,983		$	3.02		3.8	$	-
	The exercise price of these warrants ranges from $2.50 to $17.50 per share.
	During 2013, an aggregate of 65,050 warrants were exercised for cash proceeds of $176,819.
	During 2014, the Company modified an aggregate of 860,150 of warrants to reduce their exercise price from a range of $12.00 to $17.50 per share to $2.50 per share.  All other terms and conditions remained the same.  The Company determined that this transaction did not constitute a modification under ASC 718-10 or ASC 505-50 as it met the scope exceptions for a transaction with an investor or lender.  Accordingly, no expense was recognized in connection with these transactions.

Commitments_and_Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2014
Commitments and Contingencies [Abstract]
Commitments and Contingencies	Note 8. Commitments and Contingencies
	Under the 2013 Research Agreement with USC, the Company is obligated to make certain payments to USC based on work performed by USC under that agreement, and by Michigan under its subcontractor agreement with USC. (See Note 1)
	Under the terms of the 2013 Amended License Agreement, the Company is required to make minimum royalty payments to Princeton. (See Note 1)
	The Company has agreements with three executive officers which provide for certain cash and other benefits upon termination of employment of the officer in connection with a change in control of the Company. Each executive is entitled to a lump-sum cash payment equal to three times the sum of the average annual base salary also they are entitled to a cash bonus.
	In November 2013, the Company entered into a 60-month lease agreement for its corporation facility in Arizona. Total rent expense for the year ended December 31, 2014 and 2013 was $80,584 and $44,665, respectively.
	Future minimum lease payments are as follows:
	Years ending December 31,
	2015	$	79,617
	2016		81,925
	2017		84,233
	2018		71,797
	2019		-
	Thereafter		-
	Total	$	317,572

Income_Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2014
Income Taxes [Abstract]
Income Taxes	Note 9. Income Taxes
	The Company has incurred losses since inception.  As of December 31, 2014, the Company has net operating loss carry-forwards of approximately $57,000,000 that begin to expire in 2017.   Pursuant to Sections 382 and 383 of the Internal Revenue Code, the utilization of NOLs and other tax attributes may be subject to substantial limitations if certain ownership changes occur during a three-year testing period (as defined by the Internal Revenue Code). A valuation allowance was established for all the net deferred tax assets because realization is not assured. The components of the deferred tax assets consist of the following:
		December 31,
		2014			2013
	Net operating losses	$	19,000,000		$	17,300,000
	Less: valuation allowance		(19,000,000	)		(17,300,000	)
	Net deferred tax assets	$	-		$	-

Subsequent_Events

Subsequent Events	12 Months Ended
	Dec. 31, 2014
Subsequent Events [Abstract]
Subsequent Events	Note 10. Subsequent Events
	From January 5, 2015 through March 16, 2015, the Company offered to reduce the exercise price of certain warrants of the Company to $0.50 as an incentive to the holders to exercise such warrants (“Warrant Price Reduction”). As a result of the Warrant Price Reduction, a total of 649,650 shares of our Common Stock were issued after exercise of these warrants in exchange for $324,825 of proceeds. Company determined that this transaction did not constitute a modification under ASC 718-10 or ASC 505-50 as it met the scope exceptions for a transaction with an investor or lender.  Accordingly, no expense was recognized in connection with these transactions.
	In March 2015, the Company received aggregate proceeds of $700,000 in exchange convertible notes and the issuance of warrants with a five year life and an exercise price of $2.5 per share.  The convertible notes bear an interest of 8% per annum, a maturity date of December 19, 2015, and is convertible into units, with each unit consisting of a share of common stock and a warrant with a five year life from the date of conversion and an exercise price of $1 per share, subject to certain anti-dilution provisions.
	From January 2015 to March 2015, the Company sold an aggregate of 86,000 units at $1.00 per unit for aggregate proceeds of $86,000. Each unit consisted of one common share and one warrant. Each warrant is exercisable for a period of five years from the date of issuance, at $1.00 per share.

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2014
Summary of Significant Accounting Policies [Abstract]
Cash and Cash Equivalents	Cash and Cash Equivalents
	For purposes of the statement of cash flows, the Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents.
Principles of Consolidation	Principles of Consolidation
	The consolidated financial statements include the accounts of the Company and its controlled subsidiaries. Equity investments in which we exercise significant influence, but do not control and are not the primary beneficiary, are accounted for using the equity method of accounting. Investments in which we do not exercise significant influence over the investee are accounted for using the cost method of accounting. Intercompany transactions are eliminated.
Property and Equipment	Property and Equipment
	Property and equipment are stated at cost.  Depreciation of property and equipment is provided using the straight-line method for financial reporting purposes at rates based on the estimated useful lives of the assets.  Estimated useful lives range from three to eight years.
Impairment of Long-lived Assets	Impairment of Long-lived Assets
	The Company reviews the carrying value of its long-lived assets annually or whenever events or changes in circumstances indicate that the historical-cost carrying value of an asset may no longer be appropriate. The Company assesses recoverability of the asset by comparing the undiscounted future net cash flows expected to result from the asset to its carrying value. If the carrying value exceeds the undiscounted future net cash flows of the asset, an impairment loss is measured and recognized. An impairment loss is measured as the difference between the net book value and the fair value of the long-lived asset. Fair value is estimated based upon either discounted cash flow analysis or estimated salvage value.
Stock-Based Compensation	Stock-Based Compensation
	We account for stock based compensation in accordance with FASB ASC 718 which requires companies to measure the cost of employee services received in exchange for an award of an equity instrument based on the grant-date fair value of the award. For stock-based awards granted on or after January 1, 2006, stock-based compensation expense is recognized on a straight-line basis over the requisite service period. In prior years, we accounted for stock-based awards under APB No. 25, “Accounting for Stock Issued to Employees.” We account for non-employee share-based awards in accordance with FASB ASC 505-50.
Use of Estimates	Use of Estimates
	The preparation of these financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that may affect certain reported amounts and disclosures in the financial statements and accompanying notes. The significant estimates relate useful lives of software licenses, valuation of beneficial conversion feature on convertible debts, valuation of warrants and stock options, and valuation allowance for deferred income taxes. Actual results could differ from those estimates.
Credit Risk	Credit Risk
	Cash is maintained in bank accounts which, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts and does not believe it is exposed to any significant credit risk on cash.
Research and Development	Research and Development
	Research and development costs are expensed in the period they are incurred in accordance with ASC 730, Research and Development unless they meet specific criteria related to technical, market and financial feasibility, as determined by management, including but not limited to the establishment of a clearly defined future market for the product, and the availability of adequate resources to complete the project. If all criteria are met, the costs are deferred and amortized over the expected useful life, or written off if a product is abandoned. At December 31, 2014 and 2013, the Company had no deferred development costs.
Fair Value of Financial Instruments	Fair Value of Financial Instruments
	The carrying value of short-term financial instruments, including cash, accounts receivable, accounts payable and accrued expenses, and short-term borrowings approximate fair value due to the relatively short period to maturity for these instruments. The long-term borrowings approximate fair value since the related rates of interest approximates current market rates.
Income Taxes	Income Taxes
	Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. These assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which the temporary differences are expected to reverse.
	We have net operating loss carry-forwards available to reduce future taxable income. Future tax benefits for these net operating loss carry-forwards are recognized to the extent that realization of these benefits is considered more likely than not. To the extent that we will not realize a future tax benefit, a valuation allowance is established.

Background_Basis_of_Presentati1

Background, Basis of Presentation (Tables)	12 Months Ended
	Dec. 31, 2014
Background, Basis of Presentation [Abstract]
Summary of royalty revenue	Years ending December 31,
	2015	40,000
	2016	50,000
	2017	65,000
	2018	75,000
	2019	100,000
	2020 and thereafter	100,000

Stock_Options_and_Warrants_Tab

Stock Options and Warrants (Tables)	12 Months Ended
	Dec. 31, 2014
Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Summary of stock option activity							Weighted
							Average
					Weighted		Remaining
		Number of			Average		Contractual		Aggregate
					Exercise		Term		Intrinsic
		Shares			Price		(in years)		Value
	Outstanding as of December 31, 2012		137,000		$	9.7		1.9	$	-
	Granted		-
	Cancelled		(32,000	)	$	10.06
	Exercised		-
	Outstanding as of December 31, 2013		105,000		$	11.03		2.6	$	-
	Granted		-
	Cancelled		(56,000	)	$	10.26
	Exercised		-
	Outstanding as of December 31, 2014		49,000		$	11.01		1.8	$	-
	Exercisable as of December 31, 2014		49,000		$	11.92		1.8	$	-
Warrant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Summary of stock option activity
							Weighted
							Average
					Weighted		Remaining
		Number of			Average		Contractual		Aggregate
					Exercise		Term		Intrinsic
		Shares			Price		(in years)		Value
	Outstanding as of December 31, 2012		2,007,083		$	13.9		14	$	-
	Granted		17,639,700		$	0.4
	Cancelled		(24,750	)	$	5.56
	Exercised		(65,050	)	$	13.36
	Outstanding as of December 31, 2013		19,556,983		$	3.6		4.7	$	-
	Granted		1,707,000		$	2.5
	Cancelled		(12,000	)
	Exercised		-
	Outstanding as of December 31, 2014		21,251,983		$	3.02		3.8	$	-
	Exercisable as of December 31, 2014		21,251,983		$	3.02		3.8	$	-

Commitments_and_Contingencies_

Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2014
Commitments and Contingencies [Abstract]
Schedule of future minimum lease payments
	Years ending December 31,
	2015	$	79,617
	2016		81,925
	2017		84,233
	2018		71,797
	2019		-
	Thereafter		-
	Total	$	317,572

Income_Taxes_Tables

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2014
Income Taxes [Abstract]
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]
		December 31,
		2014			2013
	Net operating losses	$	19,000,000		$	17,300,000
	Less: valuation allowance		(19,000,000	)		(17,300,000	)
	Net deferred tax assets	$	-		$	-

Background_Basis_of_Presentati2

Background, Basis of Presentation (Details) (License Agreement Terms [Member], USD $)	12 Months Ended
	Dec. 31, 2014
2015 [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Royalty revenue	$40,000
2016 [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Royalty revenue	50,000
2017 [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Royalty revenue	65,000
2018 [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Royalty revenue	75,000
2019 [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Royalty revenue	100,000
2020 and thereafter [Member]
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Royalty revenue	$100,000

Background_Basis_of_Presentati3

Background, Basis of Presentation (Details Textual) (USD $)	12 Months Ended	1 Months Ended
	Dec. 31, 2014	Dec. 20, 2013	Sep. 24, 2013	Sep. 22, 2013	Dec. 31, 2013	Dec. 31, 2012
Background Basis of Presentation (Textual)
Common Stock, par value per share	$0.00				$0.00
Shares, issued					1,155,000
Shares, outstanding
Royalties due percentage	23.00%
License Agreement [Member]
Background Basis of Presentation (Textual)
Royalties due percentage	3.00%
Sponsored Research Agreement [Member]
Background Basis of Presentation (Textual)
Research and development agreement description		On December 20, 2013, the Company entered into a Research Agreement with USC ("2013 Research Agreement") to amend and replace the 2009 Research Agreement to continue the sponsored research at USC and Michigan from February 1, 2014 through January 31, 2021.	Research and development of the Technology is being conducted at the University of Southern California ("USC") and, on a subcontractor basis, at the University of Michigan, beginning 2006 and currently under a 5-year Sponsored Research Agreement dated May 1, 2009.
Cash paid for research and development			$6,338,341
Common Stock [Member]
Background Basis of Presentation (Textual)
Shares, outstanding	44,306,278				42,799,278	16,091,909
UTCH [Member]
Background Basis of Presentation (Textual)
Common Stock, par value per share				$0.00
Forward split, Description				1.2-for-1 forward split of the outstanding common stock.
UTCH [Member] | Common Stock [Member]
Background Basis of Presentation (Textual)
Shares, issued			15,500,640
Common stock, ownership percentage			80.00%
Cancellation of common stock warrants			1,917,283
Cancellation of options			105,000
UTCH [Member] | Series A Preferred Stock [Member]
Background Basis of Presentation (Textual)
Shares, issued			5,780,500
Warrants to be issued			5,780,500
UTCH [Member] | Convertible Debt [Member]
Background Basis of Presentation (Textual)
Warrants to be issued			11,433,200
GPEC [Member] | Common Stock [Member]
Background Basis of Presentation (Textual)
Shares, issued			77,503,198
Warrants to be issued			9,586,416
Common stock, ownership percentage			100.00%
GPEC [Member] | Series A Preferred Stock [Member]
Background Basis of Presentation (Textual)
Shares, issued			5,255
Shares, outstanding			5,255
Description of common shares and warrants receivable			GPEC shareholders of the Company as of September 24, 2013 received 1 common share of UTCH, Inc. for each 5 common shares, warrants, options and 1,100 common shares for each series A Preferred convertible stock owned of GPEC.
GPEC [Member] | Employee Stock Option [Member]
Background Basis of Presentation (Textual)
Shares, issued			525,000
GPEC [Member] | Convertible Debt [Member]
Background Basis of Presentation (Textual)
Convertible notes			$11,433,200

Going_Concern_Details

Going Concern (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Going Concern [Textual]
Accumulated deficit	($178,226,456)	($172,263,028)
Working capital deficit	$5,210,230

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Details)	12 Months Ended
	Dec. 31, 2014
Summary of Significant Accounting Policies (Textual)
Property and equipment, depreciation method	Straight-line method.
Property and equipment, estimated useful lives	Estimated useful lives range from three to eight years.

Debt_Details

Debt (Details) (USD $)	12 Months Ended			1 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Nov. 30, 2014	Feb. 26, 2014	Dec. 19, 2014	Jul. 31, 2014	Sep. 24, 2013
Debt (Textual)
Repayment of notes payable		$1,725,000
Aggregate debt amount		230,000	270,000
Outstanding debt	100,000	100,000
Amortization of debt discounts	4,304	45,421
Borrowings on related party debt	150,000	240,000
Borrowings from private investors	700,000
Warrants exercisable term	5 years	5 years
Warrants exercisable price per share	$2.50	$2.50
Accounts payable- related party	48,064
Notes Payable [Member]
Debt (Textual)
Debt instrument face amount		1,758,900
Outstanding debt		1,400,000
Common stock issued in connection with debt		286,000
Amortization of debt discounts		45,421
Notes Payable [Member] | Mr. Seligsohn [Member]
Debt (Textual)
Debt instrument interest rate	0.50%
Notes Payable [Member] | Third Party [Member]
Debt (Textual)
Repayment of notes payable		1,725,000
Aggregate debt amount		230,000
Common shares issued for conversion		46,000
Debt instrument face amount		282,900
Loss on debt extinguishment		52,900
Notes Payable - Related Party [Member]
Debt (Textual)
Debt instrument interest rate					18.00%
Borrowings on related party debt					150,000
Unsecured note, maturity date				26-Feb-15
Debt instrument, accrued interest	22,784
Debt instrument description					Under the terms of this agreement, this note is due to be repaid within 6 months of funding and is non-interest bearing.
Advances - Related Party [Member] | Mr. Seligsohn [Member]
Debt (Textual)
Advance from related party	721,150
Advance repaid		293,000
Convertible Notes Payable [Member]
Debt (Textual)
Aggregate debt amount						300,000
Common shares issued for conversion								4,557,000
Debt instrument face amount						300,000	250,000
Outstanding debt		2,432,500
Debt instrument interest rate		5.00%				8.00%
Borrowings on related party debt							500,000
Unsecured note, maturity date						19-Dec-15	21-Jul-15
Debt instrument, accrued interest	50,000
Borrowings from private investors		2,124,500
Warrants purchase price		1				1
Unsecured note conversion price	$1.25	$2.50
Warrants issued for conversion of notes						200,000		4,557,000
Interest due to be repaid							16,500
Increase in interest amount							25,000
Debt instrument description	There is no BCF since the conversion is $1.25 which equal to the $1.25 units being sold.
Warrants exercisable price per share						$2.50
Convertible Notes Payable - Related Party [Member]
Debt (Textual)
Common shares issued for conversion		115,500						6,800,000
Debt instrument face amount		57,915
Debt instrument interest rate		5.00%
Borrowings on related party debt		240,000
Unsecured note, maturity date		31-Dec-13
Debt instrument, accrued interest		105,000
Advance repaid		563,800
Borrowings from private investors		6,800,000
Warrants purchase price		2.5
Warrants issued for conversion of notes								6,800,000
Unsecured note interest		5.00%
Short-term debt, balance due		100,000
Convertible Notes Payable - Related Party [Member] | Warrant [Member]
Debt (Textual)
Common shares issued for conversion								76,200
Warrants issued for conversion of notes								76,200
Convertible Debt [Member]
Debt (Textual)
Aggregate debt amount						71,369
Amortization of debt discounts						130,915
Interest due to be repaid	4,304
Amount allocated for warrants						$59,546

Equity_Details

Equity (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Common shares issued for warrant exercise		$176,819
Common shares issued for services		25,971,940
Common shares issued for loan extensions		1,758,900
Common shares issued to debt holders for additional interest		1,067,345
Common shares issued for default penalty interest		2,214,000
Common shares issued to warrant holders for additional interest		733,695
Common shares issued for consulting services		92,250
Common shares issued for debt conversions		282,900
Common stock issued for cash		1,050,000
Common shares issued for forgiveness of debt		162,915
Converted note interest due amount		105,000
Sale of common shares and warrants in PPM		532,500
Sale of stock and warrant, per share price	$1.25	$1.25
Class Of Warrant Exercisable Period In Force	5 years	5 years
Warrants exercisable price per share	$2.50	$2.50
Distribution to shareholders for return on equity investment		130,000
Equity investment from shareholders		225,000
Sales of common shares	1,883,750
Sale of stock and warrant, description	Each unit consisted of one common share and one warrant. Each warrant is exercisable for a period of five years from the date of issuance, at $2.50 per share.
Common Stock [Member]
Common shares issued for warrant exercise (in shares)		60,070
Common shares issued for warrant exercise		6
Common shares issued for services (in shares)		2,858,811
Common shares issued for services		286
Common shares issued for loan extensions (in shares)		286,000
Common shares issued for loan extensions		29
Common shares issued to debt holders for additional interest (in shares)		173,552
Common shares issued to debt holders for additional interest		17
Common shares issued for default penalty interest (in shares)		360,000
Common shares issued for default penalty interest		36
Common shares issued to warrant holders for additional interest (in shares)		119,300
Common shares issued to warrant holders for additional interest		12
Common shares issued for consulting services (in shares)		15,000
Common shares issued for consulting services
Common shares issued for debt conversions (in shares)		46,000
Common shares issued for debt conversions		5
Common shares issued for cash (in shares)		1,155,000
Common stock issued for cash		116
Common shares issued for forgiveness of debt (in shares)		115,500
Common shares issued for forgiveness of debt		12
Reverse merger adjustment (in shares)		9,658,936
Sale of common shares and warrants in PPM (in shares)		426,000
Sale of common shares and warrants in PPM		43
Sales of common shares, Shares	1,507,000
Sales of common shares	$151

Stock_Options_and_Warrants_Det

Stock Options and Warrants (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Number of Shares, Outstanding			137,000
Weighted Average Exercise Price, Outstanding			$9.70
Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Number of Shares, Outstanding	105,000	137,000
Number of shares, Granted
Number of Shares, Cancelled	-56,000	-32,000
Number of Shares, Exercised
Number of Shares, Outstanding	49,000	105,000	137,000
Number of Shares, Exercised	49,000
Weighted Average Exercise Price, Outstanding	$11.03	$9.70
Weighted Average Exercise Price, Granted
Weighted Average Exercise Price, Cancelled	$10.26	$10.06
Weighted Average Exercise Price, Exercised
Weighted Average Exercise Price, Outstanding	$11.01	$11.03	$9.70
Weighted Average Exercise Price, Exercisable	$11.92
Weighted Average Remaining Contractual Term (in years), Outstanding	1 year 9 months 18 days	2 years 7 months 6 days	1 year 10 months 24 days
Weighted Average Remaining Contractual Term (in years), Exercisable	1 year 9 months 18 days
Aggregate Intrinsic Value, Outstanding
Aggregate Intrinsic Value, Exercisable
Warrant [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Number of Shares, Outstanding	19,556,983	2,007,083
Number of shares, Granted	1,707,000	17,639,700
Number of Shares, Cancelled	-12,000	-24,750
Number of Shares, Exercised		-65,050
Number of Shares, Outstanding	21,251,983	19,556,983	2,007,083
Number of Shares, Exercised	21,251,983
Weighted Average Exercise Price, Outstanding	$3.60	$13.09
Weighted Average Exercise Price, Granted	$2.50	$0.40
Weighted Average Exercise Price, Cancelled		$5.56
Weighted Average Exercise Price, Exercised		$13.36
Weighted Average Exercise Price, Outstanding	$3.02	$3.60	$13.09
Weighted Average Exercise Price, Exercisable	$3.02
Weighted Average Remaining Contractual Term (in years), Outstanding	3 years 9 months 18 days	4 years 8 months 12 days	14 years
Weighted Average Remaining Contractual Term (in years), Exercisable	3 years 9 months 18 days
Aggregate Intrinsic Value, Outstanding
Aggregate Intrinsic Value, Exercisable

Stock_Options_and_Warrants_Det1

Stock Options and Warrants (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Stock Options And Warrants (Textual)
Number of options to purchase common stock	2,000,000
Warrants granted during the period	860,150
Stock Options [Member] | Minimum [Member]
Stock Options And Warrants (Textual)
Exercise price of options/warrants	10
Stock Options [Member] | Maximum [Member]
Stock Options And Warrants (Textual)
Exercise price of options/warrants	15
Warrant [Member]
Stock Options And Warrants (Textual)
Warrants exercised		65,060
Proceeds from warrants exercised		$176,819
Warrant [Member] | Minimum [Member]
Stock Options And Warrants (Textual)
Exercise price of options/warrants	2.5
Warrant [Member] | Maximum [Member]
Stock Options And Warrants (Textual)
Exercise price of options/warrants	17.5
Warrant [Member] | Exercise Price Range One [Member] | Minimum [Member]
Stock Options And Warrants (Textual)
Exercise price of options/warrants	12
Warrant [Member] | Exercise Price Range One [Member] | Maximum [Member]
Stock Options And Warrants (Textual)
Exercise price of options/warrants	17.5
Warrant [Member] | Exercise Price Range Two [Member]
Stock Options And Warrants (Textual)
Exercise price of options/warrants	2.5

Commitments_and_Contingencies_1

Commitments and Contingencies (Details) (USD $)	Dec. 31, 2014
Schedule of future minimum lease payments
2015	$79,617
2016	81,925
2017	84,233
2018	71,797
2019
Thereafter
Total	$317,572

Commitments_and_Contingencies_2

Commitments and Contingencies (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Commitments and Contingencies (Textual)
Rent expense	$80,584	$44,665
Lease agreement [Member]
Commitments and Contingencies (Textual)
Term of lease agreement		60 months

Income_Taxes_Details

Income Taxes (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Components of Deferred Tax Assets and Liabilities [Abstract]
Net operating losses	$19,000,000	$17,300,000
Less: valuation allowance	-19,000,000	-17,300,000
Net deferred tax assets

Income_Taxes_Details_Textual

Income Taxes (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2014
Income Taxes (Textual)
Net operating loss carry forwards	$57,000,000
Expiration period	31-Dec-17

Subsequent_Events_Details

Subsequent Events (Details) (USD $)	12 Months Ended		0 Months Ended	3 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Mar. 31, 2015	Mar. 16, 2015	Mar. 31, 2015
Subsequent Events (Textual)
Proceeds from exercise of warrants		$176,819
Warrants exercisable term	5 years	5 years
Proceeds from convertible notes		2,124,500
Subsequent Event [Member]
Subsequent Events (Textual)
Proceeds from exercise of warrants				324,825
Warrants exercise			$2.50	$0.50
Common stock issued in exercise of warrants				649,650
Warrants exercisable term			5 years
Proceeds from convertible notes			700,000
Convertible note interest percentage				8.00%
Convertible note maturity date			19-Dec-15
Convertible note conversion, Description			Each unit consisting of a share of common stock and a warrant with a five year life from the date of conversion and an exercise price of $1 per share, subject to certain anti-dilution provisions.
Number of convertible note units sold					86,000
Proceeds from sale of convertible note units					$86,000
Convertible note unit price					$1
Convertible note unit, Description					Each warrant is exercisable for a period of five years from the date of issuance, at $1.00 per share.
Convertible note unit exercisable term					5 years